Evidence map›Paper›PMID 30386343›Full record

ArticleFrontiers in immunology2018

LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy.

Pere Soler-Palacín, Marina Garcia-Prat, Andrea Martín-Nalda, Clara Franco-Jarava, Jacques G Rivière, Alberto Plaja, Daniela Bezdan, Mattia Bosio, Mónica Martínez-Gallo, Stephan Ossowski and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Early-Onset Diabetes in an Infant with a Novel Frameshift Mutation in LRBA.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Various phenotypes ofInternational journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Pere Soler-PalacínPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Marina Garcia-PratPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Andrea Martín-NaldaPediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Clara Franco-JaravaJeffrey Modell Foundation Excellence Center, Barcelona, Spain.
Jacques G RivièrePediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Alberto PlajaDepartment of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Daniela BezdanCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Mattia BosioCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Mónica Martínez-GalloJeffrey Modell Foundation Excellence Center, Barcelona, Spain.
Stephan OssowskiCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Roger ColobranJeffrey Modell Foundation Excellence Center, Barcelona, Spain.
Vall d'Hebron Institut de Recerca · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ESCentre for Genomic Regulation · ESPompeu Fabra University · ESUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LRBA deficiency was first described in 2012 as an autosomal recessive disorder caused by biallelic mutations in the

Indexed as

Chromosomes, Human, Pair 4Genetic Association StudiesGenetic Predisposition to DiseaseHomozygoteMutationUniparental DisomyAdaptor Proteins, Signal TransducingComparative Genomic HybridizationExome SequencingHumansLeukocytesLymphocytesAdaptor Proteins, Signal TransducingLRBA protein, humancomparative genomic hybridization arrayLRBA deficiencyprimary immunodeficiencyuniparental disomywhole exome sequencing

Identifiers

PMID30386343
PMCPMC6198091
OpenAlexW2892921031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.